NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or ...
Please provide your email address to receive an email when new articles are posted on . The addition of chemotherapy to radiotherapy did not improve OS in intermediate-risk cervical cancer. Patients ...
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...
An initiative at Kaiser Permanente Washington suggests that providing self-collect cervical cancer test kits for patients (to ...
Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical ...
How Was Keytruda Studied for Cervical Cancer? Keytruda was studied in people who had cervical cancer that was newly diagnosed, high risk, locally advanced, and who had not received any prior treatment ...
The Commonwealth Secretariat today launched the first edition of a Compendium of Country Case Studies on Cervical Cancer Elimination at the 2026 Inaugural Commonwealth Health Coordination Forum in ...
Cervical cancer may be more common in people over 60 years old than originally believed. However, current screenings suggest that individuals over the age of 65 no longer receive regular cervical ...
The cervix and uterus are connected. But cervical cancer and uterine cancer are different in their underlying causes, symptom presentation, and the location where cancer cells originate. Cervical ...
Introduction Cervical cancer remains a major health concern in low-resource settings, with Cambodian women experiencing some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results